Malignancy following treatment of rheumatoid arthritis with cyclophosphamide
- 1 July 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 83 (1) , 1-9
- https://doi.org/10.1016/0002-9343(87)90490-6
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Heavy Phenacetin Use and Bladder Cancer in Women Aged 20 to 49 YearsNew England Journal of Medicine, 1985
- Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis?New England Journal of Medicine, 1983
- The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.Annals of the Rheumatic Diseases, 1983
- Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritisArthritis & Rheumatism, 1983
- Defective EBV-Specific Suppressor T-Cell Function in Rheumatoid ArthritisNew England Journal of Medicine, 1981
- CYCLOSPORIN A IMMUNOSUPPRESSION, EPSTEIN-BARR ANTIBODY, AND LYMPHOMAThe Lancet, 1980
- Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritisJournal of Chronic Diseases, 1978
- Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1974
- Neoplasia and CyclophosphamideArthritis & Rheumatism, 1973
- Immunosurveillance and cancer: epidemiological evidence.BMJ, 1970